Like TFR1, shRNA knockdown of HSPA9 results in a major proliferation inhibition of breast cancer and, particularly, of melanoma cells, regardless of MEMO1 expression level (Figure 2—figure supplement 4). The gene discussed is TFRC; the disease is breast cancer.